Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) — The Wave

Recent Stories

Keeping the Human in Medicine: Two AI CoLab Researchers on What Machines Can’t ReplaceSomeone Is Hacking the Freezers. Pay Attention.Thinking of Running in 2028? Start HereWhat the Lame Duck Session Has to Do With the Ultimate 21st-Century Power Tool: RobotsBlack October Wasn't an Attack Wave. It Was a Warning.Extreme Ownership Means Ultimate Achievement – NASA Culture Shift

← Back to the board

Opportunity · Grant

Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)

Department of Health and Human Services

At a glance

Solicitation: RFAAI28024
Value: $4M ceiling
Responses due: Feb 11 · Closes in 88 days

Lifecycle

1 notice

GrantNational Institutes of HealthOct 13NIH seeks applications for research and preclinical development of next-generation malaria vaccines under RFA-AI-28-024, with a $4 million ceiling.$4M ceilingCloses in 88 daysRFA-AI-28-024 (R61/R33 Clinical Trial Not Allowed)BiotechLifecycle 12 linked

Analytics cookies help us see how the site is used. They only run if you accept. Privacy Policy

Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) — The Wave